ARTICLE | Company News
Amrad, CAT rheumatoid arthritis deal
December 19, 2001 8:00 AM UTC
Cambridge Antibody Technology (LSE:CAT; CATG) and cytokine biology play Amrad (ASX:AML) partnered to develop human antibodies to treat rheumatoid arthritis through neutralization of the receptor for g...